Skip to main content

Table 3 Study outcomes

From: INtervention for Cognitive Reserve Enhancement in delaying the onset of Alzheimer’s Symptomatic Expression (INCREASE), a randomized controlled trial: rationale, study design, and protocol

Study outcomes
Primary Medication appropriateness MAI Change from pre- to post-intervention
Executive function TMTB CRCS: difference in scopolamine-challenged and unchallenged z-scores
Secondary Global cognition MoCA
Memory CVLT
Perceived health status SF-36 Change from pre- to post-intervention
  1. MAI medication appropriateness index, TMTB Trail Making Test B, CVLT California Verbal Learning Test, MoCA Montreal Cognitive Assessment, SF-36 Short-Form 36